Evidence map›Paper›PMID 40169460›Full record

ArticleCellular and molecular neurobiology2025

Downregulation of Hmox1 and Rpgrip1l Expression Linked to Risk-Taking Behavior, Reduced Depressive Symptoms, and Diminished Novelty Socialization in SUMO1 Knockout Mice.

Qiwei Dai, Yuxiang Wang, Hongbin Xu, He Dong, Fang Nie, Lianxue Zhang, Xiaozhi Liu, Zhiqing Li

Abstract read
In one paragraph

Article in Cellular and molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qiwei Dai *Department of Stroke Center, The First Hospital of China Medical University, Shenyang, 110001, Liaoning, People's Republic of China.ORCID http://orcid.org/0009-0004-3813-5661
Yuxiang Wang *Central Laboratory, Tianjin Key Laboratory of Epigenetic for Organ Development of Preterm Infants, Tianjin Fifth Central Hospital, Tianjin, 300450, People's Republic of China.ORCID http://orcid.org/0000-0002-7241-7556
Hongbin XuDepartment of Neurosurgery, The First Hospital of China Medical University, Shenyang, 110001, Liaoning, People's Republic of China.ORCID http://orcid.org/0009-0002-7584-8340
He DongDepartment of Stroke Center, The First Hospital of China Medical University, Shenyang, 110001, Liaoning, People's Republic of China.ORCID http://orcid.org/0009-0001-4553-6277
Fang NieDepartment of Stroke Center, The First Hospital of China Medical University, Shenyang, 110001, Liaoning, People's Republic of China.ORCID http://orcid.org/0009-0008-7087-3372
Lianxue ZhangDepartment of Stroke Center, The First Hospital of China Medical University, Shenyang, 110001, Liaoning, People's Republic of China.ORCID http://orcid.org/0009-0008-2249-4642
Xiaozhi LiuCentral Laboratory, Tianjin Key Laboratory of Epigenetic for Organ Development of Preterm Infants, Tianjin Fifth Central Hospital, Tianjin, 300450, People's Republic of China.ORCID http://orcid.org/0000-0002-5640-4472
Zhiqing LiDepartment of Stroke Center, The First Hospital of China Medical University, Shenyang, 110001, Liaoning, People's Republic of China. dr_lizhiqing@163.com.ORCID http://orcid.org/0000-0003-3579-1271

Funding

National Clinical Key Specialty Construction Project of the Emergency Department No. 2023283Noncommunicable Chronic Diseases-National Science and Technology Major Project No. 2023ZD0505600Shenyang Science and Technology Bureau No. 21-172-9-17Tianjin Binhai New Area Health Commission Science and Technology Project No. 2023BWKQ001Tianjin Health Technology Project No. TJWJ2022XK043Tianjin Municipal Health Commission Scientific Research Project of Traditional Chinese Medicine and Integrated Chinese-Western Medicine No. 2023187Tianjin Municipal Science and Technology Plan Project No. 24ZYCGSY00650
6 · The paper itself

Abstract

SUMO1 is involved in the normal physiological functions of the nervous system and is also associated with the development of neurodegenerative diseases. Whereas, the effects and underling mechanisms of SUMO1 knockout (SUMO1- KO) on emotion- and cognition -related behaviors remain unexplored. We investigated changes in depression-like behaviors, social interaction, and cognition in SUMO1-KO mice compared to wild-type (WT) controls using the open-field test, tail suspension test, three-chamber test and novel object recognition test, respectively. To explore the underlying mechanisms of these behavioral differences, we performed Gene Ontology (GO) analysis of proteomics data and subsequently validated the findings through experimental verification. The results showed that SUMO1-KO mice exhibited increased risk-taking behavior, reduced depressive symptoms, and diminished novelty socialization compared to WT mice. Mass spectrometry-based proteomics analysis revealed 370 upregulated proteins and downregulated 84 proteins. GO annotation analysis identified significant enrichment of amino acid transmembrane transporter activities and ion channel. We further investigated two behavior-associated proteins, Hmox1 and Rpgrip1l, and validated their downregulated expression. We concluded that decreased expression of Hmox1 and Rpgrip1l associated with the risk-taking behavior, reduced depressive symptoms, and diminished novelty socialization observed in SUMO1-KO mice.

Indexed as

DepressionDown-RegulationExploratory BehaviorHeme Oxygenase-1SUMO-1 ProteinAnimalsBehavior, AnimalMaleMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutHeme Oxygenase-1Hmox1 protein, mouseMembrane ProteinsSUMO-1 ProteinExploratory behaviorsHeme oxygenase 1Mania-like phenotypeRPGR-interacting protein 1-likeSocial interactionSUMO1-KO

Identifiers

PMID40169460
PMCPMC11961799

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.